September 30th, 2021



Get Involved, Spread the Word & Hear Stories From Those Impacted ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌…

September 29th, 2021

Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue

The Chondrosarcoma CS Foundation, Inc. held the Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma survivors and prominent experts to…

September 15th, 2021

Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program

TUCSON, Ariz. and WASHINGTON, September 15, 2021 — The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP

®) officially launched its next…

September 14th, 2021

Study Description
Go to

Brief Summary:
This phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to…

September 9th, 2021

Last Notice

Chondrosarcoma CS Foundation, Inc.
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue (VIA Zoom)
Tuesday, September 14, 2021
7:30PM – 9:00PM (Eastern Standard Time / New York)

This Event is Free to…

August 31st, 2021

The Chondrosarcoma Foundation is hosting its first fundraising event to bring awareness to Chondrosarcoma: a rare bone and soft tissue cancer.

Where: The comfort of your own neighborhood!
When: anytime between October 3rd-9th
TO…

August 11th, 2021

https://www.eventbrite.com/e/steppin-for-a-cause-tickets-166736518415

August 10th, 2021

The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma Survivors and prominent experts to examine new technologies, medications, and clinical trials, as well as providing…

August 9th, 2021

Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist For more information: Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human…

August 1st, 2021

Did you know… Research initiated by the Bone Cancer Research Trust discovered that navigation guided surgery improves 5-year chondrosarcoma-specific survival from 53% to 76%!

Read about this life-saving breakthrough and many more in our new…